Ricky Hopson - 08 Dec 2023 Form 4 Insider Report for Catalent, Inc.

Role
Pres. Clinical Dev Supply Div
Signature
/s/ Amy Fallone, attorney-in-fact
Issuer symbol
N/A
Transactions as of
08 Dec 2023
Net transactions value
-$9,518
Form type
4
Filing time
12 Dec 2023, 19:24:33 UTC
Previous filing
12 Dec 2023
Next filing
05 Jun 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CTLT Common Stock Award $0 +747 +3.5% $0.000000 22,274 08 Dec 2023 Direct F1, F2
transaction CTLT Common Stock Tax liability $9,518 -256 -1.1% $37.18 22,018 08 Dec 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Received upon the achievement of the fiscal 2021-23 performance-based vesting criteria set forth in certain incentive compensation held by the reporting person under the Issuer's long-term incentive plan.
F2 Includes restricted stock units.